Cargando…

Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians

BACKGROUND: Antibodies to human neutrophil alloantigens (HNA) are involved in the pathophysiology of several clinical conditions including transfusion-related acute lung injury (TRALI), alloimmune and autoimmune neutropenia, and febrile nonhemolytic transfusion reactions leading to neutropenia. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogri, Harita, Parihar, Meghana, Kulkarni, Swati, Madkaikar, Manisha, Sharma, Jayashree, Gorakshakar, Ajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911994/
https://www.ncbi.nlm.nih.gov/pubmed/36818775
http://dx.doi.org/10.1159/000525654
_version_ 1784885115156955136
author Gogri, Harita
Parihar, Meghana
Kulkarni, Swati
Madkaikar, Manisha
Sharma, Jayashree
Gorakshakar, Ajit
author_facet Gogri, Harita
Parihar, Meghana
Kulkarni, Swati
Madkaikar, Manisha
Sharma, Jayashree
Gorakshakar, Ajit
author_sort Gogri, Harita
collection PubMed
description BACKGROUND: Antibodies to human neutrophil alloantigens (HNA) are involved in the pathophysiology of several clinical conditions including transfusion-related acute lung injury (TRALI), alloimmune and autoimmune neutropenia, and febrile nonhemolytic transfusion reactions leading to neutropenia. The cognate antigens are polymorphic structures expressed on several glycoproteins on the neutrophils, i.e., antigens HNA-1a, −1b, −1c, and −1d on Fc-γ-receptor IIIb; HNA-2 on CD177; HNA-3a and −3b on choline transporter-like protein 2; HNA-4a and −4b on CD11b/αM subunit of the αMβ2-integrin (CD11b/CD18, Mac-1, CR3); and HNA-5a and −5b on αL-subunit (CD11a) of the αLβ2 integrin (CD11a/CD18), leukocyte function associated molecule (LFA)-1. Currently, there is a lacuna of diagnostic methods for detection of HNA in India. This study aimed to determine the HNA frequencies in Indians, estimate the risk of alloimmunization, and prepare typed neutrophil panels, which can be used to detect HNA antibodies in neutropenia cases. MATERIAL AND METHODS: EDTA blood samples were collected from random 1,054 blood donors. HNA-2 was phenotyped on fresh EDTA samples using FITC labelled monoclonal anti-CD177 by flowcytometry. HNA-1 (FCGR3B) genotyping was carried out by DNA sequencing and PCR-RFLP. Antigens of HNA-3 (SLC44A2) and HNA-5 (ITGAL) were genotyped by PCR-RFLP using TaqαI and Bsp1286I restriction enzymes, respectively, while HNA-4 (ITGAM) was genotyped by PCR-SSP. RESULTS: Allele frequencies of FCGR3B*01, FCGR3B*02, and FCGR3B*03 were found to be 0.433, 0.444, and 0.087, respectively. FCGR3B*01+*02+*03− was the most common genotype (33.78%). Ten individuals showed deficiency of FCGR3B individuals, while 23 showed hyperexpression, i.e., FCGR3B*01+*02+*03+. FCGR3B*04and *05 occurred with a frequency of 0.002 and 0.024. HNA-2 was found to be a high frequency antigen occurring in 98.8% population. Four percent individuals showed atypical expression of CD177 on their neutrophils. Allele frequencies of SLC44A2*01 and SLC44A2*02were 0.812 and 0.188, respectively, and that of ITGAM*01, ITGAM*02, ITGAL*01, and ITGAL*02 were 0.9546, 0.0454, 0.2372, and 0.7628, respectively. CONCLUSION: This is the first study in India to report the frequencies of HNA among blood donors. Typed neutrophil panels identified in the present study will enable us to investigate suspected cases of immune neutropenia in future.
format Online
Article
Text
id pubmed-9911994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-99119942023-02-16 Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians Gogri, Harita Parihar, Meghana Kulkarni, Swati Madkaikar, Manisha Sharma, Jayashree Gorakshakar, Ajit Transfus Med Hemother Research Article BACKGROUND: Antibodies to human neutrophil alloantigens (HNA) are involved in the pathophysiology of several clinical conditions including transfusion-related acute lung injury (TRALI), alloimmune and autoimmune neutropenia, and febrile nonhemolytic transfusion reactions leading to neutropenia. The cognate antigens are polymorphic structures expressed on several glycoproteins on the neutrophils, i.e., antigens HNA-1a, −1b, −1c, and −1d on Fc-γ-receptor IIIb; HNA-2 on CD177; HNA-3a and −3b on choline transporter-like protein 2; HNA-4a and −4b on CD11b/αM subunit of the αMβ2-integrin (CD11b/CD18, Mac-1, CR3); and HNA-5a and −5b on αL-subunit (CD11a) of the αLβ2 integrin (CD11a/CD18), leukocyte function associated molecule (LFA)-1. Currently, there is a lacuna of diagnostic methods for detection of HNA in India. This study aimed to determine the HNA frequencies in Indians, estimate the risk of alloimmunization, and prepare typed neutrophil panels, which can be used to detect HNA antibodies in neutropenia cases. MATERIAL AND METHODS: EDTA blood samples were collected from random 1,054 blood donors. HNA-2 was phenotyped on fresh EDTA samples using FITC labelled monoclonal anti-CD177 by flowcytometry. HNA-1 (FCGR3B) genotyping was carried out by DNA sequencing and PCR-RFLP. Antigens of HNA-3 (SLC44A2) and HNA-5 (ITGAL) were genotyped by PCR-RFLP using TaqαI and Bsp1286I restriction enzymes, respectively, while HNA-4 (ITGAM) was genotyped by PCR-SSP. RESULTS: Allele frequencies of FCGR3B*01, FCGR3B*02, and FCGR3B*03 were found to be 0.433, 0.444, and 0.087, respectively. FCGR3B*01+*02+*03− was the most common genotype (33.78%). Ten individuals showed deficiency of FCGR3B individuals, while 23 showed hyperexpression, i.e., FCGR3B*01+*02+*03+. FCGR3B*04and *05 occurred with a frequency of 0.002 and 0.024. HNA-2 was found to be a high frequency antigen occurring in 98.8% population. Four percent individuals showed atypical expression of CD177 on their neutrophils. Allele frequencies of SLC44A2*01 and SLC44A2*02were 0.812 and 0.188, respectively, and that of ITGAM*01, ITGAM*02, ITGAL*01, and ITGAL*02 were 0.9546, 0.0454, 0.2372, and 0.7628, respectively. CONCLUSION: This is the first study in India to report the frequencies of HNA among blood donors. Typed neutrophil panels identified in the present study will enable us to investigate suspected cases of immune neutropenia in future. S. Karger AG 2022-07-27 /pmc/articles/PMC9911994/ /pubmed/36818775 http://dx.doi.org/10.1159/000525654 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
spellingShingle Research Article
Gogri, Harita
Parihar, Meghana
Kulkarni, Swati
Madkaikar, Manisha
Sharma, Jayashree
Gorakshakar, Ajit
Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians
title Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians
title_full Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians
title_fullStr Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians
title_full_unstemmed Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians
title_short Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians
title_sort phenotyping and genotyping of hna: prevalence, risk of alloimmunization, and hna incompatibilities in indians
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911994/
https://www.ncbi.nlm.nih.gov/pubmed/36818775
http://dx.doi.org/10.1159/000525654
work_keys_str_mv AT gogriharita phenotypingandgenotypingofhnaprevalenceriskofalloimmunizationandhnaincompatibilitiesinindians
AT pariharmeghana phenotypingandgenotypingofhnaprevalenceriskofalloimmunizationandhnaincompatibilitiesinindians
AT kulkarniswati phenotypingandgenotypingofhnaprevalenceriskofalloimmunizationandhnaincompatibilitiesinindians
AT madkaikarmanisha phenotypingandgenotypingofhnaprevalenceriskofalloimmunizationandhnaincompatibilitiesinindians
AT sharmajayashree phenotypingandgenotypingofhnaprevalenceriskofalloimmunizationandhnaincompatibilitiesinindians
AT gorakshakarajit phenotypingandgenotypingofhnaprevalenceriskofalloimmunizationandhnaincompatibilitiesinindians